Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - INSPIRE PHARMACEUTICALS INC | d8k.htm |
| EX-10.1 - API COMMERCIAL SUPPLY AGREEMENT (DENUFOSOL), DATED AS OF DECEMBER 14, 2010 - INSPIRE PHARMACEUTICALS INC | dex101.htm |
Exhibit 10.2
PARENT GUARANTEE
Groupe Novasep SAS hereby absolutely and irrevocably guarantees to Inspire the prompt and full performance, as and when the same become due or performable, of all obligations, duties and liabilities of Finorga S.A.S. under the terms of the API Commercial Supply Agreement (Denufosol) between Inspire Pharmaceuticals, Inc. and Finorga S.A.S. dated as of December 14, 2010.
| GROUPE NOVASEP SAS | ||
| By: | /s/ Jean-Yves Bauchot | |
| Name: | Mr. Jean-Yves Bauchot | |
| Title: | Chief Financial Officer | |
| By: | /s/ Frédéric Beaupré | |
| Name: | Mr. Frédéric Beaupré | |
| Title: | Chief Legal Officer | |
| Accepted by: | ||
| INSPIRE PHARMACEUTICALS, INC. | ||
| By: | /s/ Adrian Adams | |
| Name: | Adrian Adams | |
| Title: | President and Chief Executive Officer | |